The Study of Gemcitabine in the Maintenance Treatment of Advanced Non-small Cell Lung Cancer
NCT01797913
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
70
Enrollment
OTHER
Sponsor class
Conditions
THE Efficacy and Safety of Gemcitabine in the Maintenance Treatment of Advanced Non-small Cell Lung Cancer
Interventions
DRUG:
gemcitabine
Sponsor
Fudan University